Literature DB >> 9105898

Maternally inherited diabetes and deafness: a diabetic subtype associated with a mutation in mitochondrial DNA.

J A Maassen1, J M van den Ouweland, L M t Hart, H H Lemkes.   

Abstract

Diabetes mellitus is a common disease with variations in its clinical expression and different modes of pathogenesis. The purpose of this review is to discuss a recently identified diabetic subtype. Based on the triad diabetes, maternal inheritance and impaired hearing in this subtype we have proposed the name Maternally Inherited Diabetes and Deafness (MIDD). This diabetic subtype associates in the vast majority of cases with a single mutation in mitochondrial DNA, at position 3243. The clinical presentation of MIDD which can be IDDM-like or NIDDM-like, its frequency of occurrence, possible pathogenic mechanisms and the contribution of other mitochondrial DNA mutations to the development of diabetes will be discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105898     DOI: 10.1055/s-2007-978984

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  The villain with a thousand faces.

Authors:  Ashok Balasubramanyam
Journal:  J Diabetes Complications       Date:  2014-02-18       Impact factor: 2.852

2.  mt-Nd2 Allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes.

Authors:  C E Mathews; E H Leiter; O Spirina; Y Bykhovskaya; A M Gusdon; S Ringquist; N Fischel-Ghodsian
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

Review 3.  Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations.

Authors:  Carlos T Moraes; David P Atencio; Jose Oca-Cossio; Francisca Diaz
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

Review 4.  Mitochondrial diseases caused by mtDNA mutations: a mini-review.

Authors:  Anastasia I Ryzhkova; Margarita A Sazonova; Vasily V Sinyov; Elena V Galitsyna; Mariya M Chicheva; Alexandra A Melnichenko; Andrey V Grechko; Anton Yu Postnov; Alexander N Orekhov; Tatiana P Shkurat
Journal:  Ther Clin Risk Manag       Date:  2018-10-09       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.